Americans pay far higher prices for prescription drugs than do people in other wealthy countries. The reason that other countries spend so much less on drugs is that their governments negotiate prices with the pharmaceutical industry. The United States government could adopt the same approach with the Medicare drug program and use its market leverage to negotiate the same, or even lower, prices as are paid by other wealthy nations.
According to a new issue brief from Center for Economic Policy and Research, such a system would save Washington state between $500 million and $1.2 billion over 10 years. The potential savings to all states would be enormous, cumulatively between $31 billion and $73 billion over 10 years.
Every state individually could expect significant savings. California leads the way, with potential savings between $3.3 and $7.8 billion. The next six top-saving states are Florida, New York, Texas, Pennsylvania, Ohio and Illinois, all with projected savings of at least $1 billion per year. Even those states with the least potential savings, such as Wyoming, North Dakota and Vermont, would still save tens of millions of dollars over a decade.
More To Read
February 11, 2025
The rising cost of health care is unsustainable and out of control
We have solutions that put people over profits
January 29, 2025
Who is left out of the Paid Family and Medical Leave Act?
Strengthening job protections gives all workers time they need to care for themselves and their families
January 17, 2025
A look into the Department of Revenue’s Wealth Tax Study
A wealth tax can be reasonably and effectively implemented in Washington state